About this trial
The primary objective of this study is to determine whether the effect of continuous positive airway pressure (CPAP) therapy on 24-hour mean blood pressure (BP) in patients with obstructive sleep apnea (OSA) varies between symptom phenotypes.
Eligibility criteria
Qualifiers
30 to 75 years of age
Among patients with hypertension, no change in BP medication for at least 3 months.
Willing and able to give informed consent
Willing and able to complete ambulatory blood pressure monitoring at baseline and after 6-months.
Disqualifiers
Unable to apply BP cuff (e.g. arm circumference >55 cm, prior breast cancer, structural abnormalities of the arm)
Current use of CPAP or Dental Device for OSA
Category III-IV of heart failure
Presence of Cheyne-Stokes Respiration (CSR) in PSG
Trial design
Treatments tested in this trial
- CPAP therapy
Treatment groups
Sponsors and collaborators
Ohio State University
Lead sponsor
University of Pennsylvania
Collaborator
Chang Gung Memorial Hospital
Collaborator
University of Sydney
Collaborator
The University of Western Australia
Collaborator
Peking University
Collaborator
Ruijin Hospital
Collaborator
National University of Singapore
Collaborator
University of Iceland
Collaborator
Geisinger Health
Collaborator
Charite University, Berlin, Germany
Collaborator